Stock UniverseDerived research view · source repositories remain read-only

Cytokinetics, Incorporated (CYTK)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
High
Selection Score
40.39
Global Rank
363
Market Cap
7.66B
Latest Close
71.48
RS Composite
4.71% · G#1032

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-4.49%
3M
18.32%
6M
10.55%
1Y
120.55%
3Y
89.65%
5Y
227.44%
10Y
777.06%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 1.58M · 30-day average: 3.02M · Max drawdown over stored range: -72.39%

Research Snapshot

Relative Strength vs SPX

RS Composite4.71%
20D RS-4.42%
60D RS3.36%
120D RS10.63%
Global RS Rank1032 · 69.24% percentile
Qualified+ RS Rank380 · 69.79% percentile
Group ScopeQualified+
Primary RS Rank113 · 75.33% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank36 / 701
Primary Percentile95.01
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-05105.81Mn/a-640.25M-829.61M-6.84K-915.32M40.55M-955.87M0Mn/a-6.05%-7.84%-8.65%-9.03%129.84M247.21M

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$-6,839.70-0.0x$872.390.1x$-7,880.61-0.0x$-7,546.33-0.0x

Shares Diluted: 0M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue55.82870.42894.5887.5318.47488.039
Revenue Growth (YoY)107.786%26.152%34.305%-92.039%145.339%376.556%
Gross Profit-41.123-89.51-146.225-322.593-320.934-327.987
Operating Income-93.943-186.313-324.202-496.205-536.248-612.258
Free Cash Flow-2.109-191.394-310.851-415.749-399.796-534.816
Free Cash Flow Per Share-0.033-2.489-3.461-4.307-3.57-4.453
EPS (Diluted) GAAP-1.972754-2.800431-4.330141-5.451949-5.264612-6.535681
EPS Growth
EPS Non-GAAP
Gross Margin-73.66%-127.094%-154.591%4200%4200%-372.5474%
Operating Margin-168.272%-264.544%-342.752%-6589.708%-2902.717%-695.44%
Profit Margin-228.004%-305.722%-411.21%-6988.632%-3191.112%-891.599%
Free Cash Flow Margin-3.778%-271.758%-328.637%-5521.235%-2164.101%-607.476%
Shares Outstanding (Diluted)64.52476.88689.82596.524111.979120.103
Shares Change (YoY)12.069%19.159%16.829%7.458%16.012%7.255%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-0519.36Mn/a-183.62M-9.49%-206.03M-10.64%-1.67123.27K129.84M247.21Mprocessed
2025 Q42026-02-2617.75Mn/a-178.37M-10.05%-183.03M-10.31%-1.49K122.46K122.52M246.38Mprocessed
2025 Q32025-11-051.94Mn/a-166.75M-86.13%-306.18M-158.15%-2.55119.98K225.47M158.75Mprocessed
2025 Q22025-08-0766.77Mn/a-111.51M-1.67%-134.37M-2.01%-1.12119.46K74.94M159.06Mprocessed
2025 Q12025-05-061.58Mn/a-155.63M-98.56%-161.38M-102.20%-1.36118.50K73.68M92.03Mprocessed
2024 Q42025-02-2716.93Mn/a-139.04M-8.21%-150.02M-8.86%-1.27K118.12K94.86M93.23Mprocessed
2024 Q32024-11-07463.00Kn/a-140.80M-304.11%-160.54M-346.75%-1.36117.69K46.89M93.02Mprocessed
2024 Q22024-08-09249.00Kn/a-130.17M-522.78%-143.32M-575.57%-1.31109.24K190.14M92.83Mprocessed
2024 Q12024-05-10835.00Kn/a-126.23M-151.18%-135.64M-162.45%-1.33101.92K119.98M56.82Mprocessed
2023 Q42024-02-281.67Mn/a-127.42M-76.21%-136.90M-81.88%-1.38K99.10K113.02M58.38Mprocessed
2023 Q32023-11-03378.00Kn/a-122.27M-323.45%-129.42M-342.39%-1.3596.07K99.69M60.88Mprocessed
2023 Q22023-08-03867.00Kn/a-122.05M-140.77%-128.64M-148.37%-1.3495.75K68.64M62.49Mprocessed
2023 Q12023-05-054.61Mn/a-124.47M-26.98%-131.29M-28.46%-1.3895.16K101.62M64.11Mprocessed
2022 Q42023-03-011.96Mn/a-127.03M-64.91%-137.38M-70.20%-1.45K94.72K65.58M63.81Mprocessed
2022 Q32022-11-042.52Mn/a-108.44M-43.12%-142.31M-56.58%-1.5293.76K106.24M63.54Mprocessed
2022 Q22022-08-0588.97Mn/a-10.87M-12.22%-19.82M-22.28%-0.2385.73K93.63M62.34Mprocessed
2022 Q12022-05-061.15Mn/a-77.86M-67.82%-89.44M-77.91%n/an/a115.42M61.16Mprocessed
2021 Q42022-02-2555.60Mn/a-21.70M-39.04%-30.57M-54.98%n/an/a112.67M47.37Mprocessed
2021 Q32021-11-055.44Mn/a-69.20M-12.73%-76.09M-13.99%n/an/a90.56M30.20Mprocessed
2021 Q22021-08-062.84Mn/a-54.80M-19.27%-61.55M-21.65%n/an/a37.15M35.54Mprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.